Comparing the roles of antibodies to nontyphoidal Salmonella enterica in high- and low-income countries and implications for vaccine development

Clinical and Vaccine Immunology

Volumn 20, Issue 10, 2013, Pages 1487-1490

  MacLennan, Calman A ^a,b   Tennant, Sharon M ^c,d  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c University of Maryland School of Medicine Center for Vaccine Development   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CD4 ANTIGEN; FLAGELLIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVE VACCINE; O ANTIGEN; O ANTIGEN FLAGELLIN GLYCOCONJUGATE VACCINE; OUTER MEMBRANE PROTEIN; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

AFRICA; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ECONOMIC DEVELOPMENT; ENVIRONMENTAL SANITATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOGENICITY; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; NONTYPHOIDAL SALMONELLA ENTERICA; NOTE; PASSIVE IMMUNIZATION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; TYPHOID FEVER; UNITED STATES; VACCINE PRODUCTION;

BLOOD BACTERICIDAL ACTIVITY; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SERUM;

EID: 84886744302     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00465-13     Document Type: Note

References (36)

1. Trebicka E, Jacob S, Pirzai W, Hurley BP, Cherayil BJ. 2013. Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States. Clin. Vaccine Immunol. 20:1491-1498.
2. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. 2012. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379:2489-2499.
3. MacLennan CA, Levine MM. 2013. Invasive nontyphoidal Salmonella disease in Africa: current status. Expert Rev. Anti Infect. Ther. 11:443-446.
4. Okoro CK, Kingsley RA, Connor TR, Harris SR, Parry CM, Al-Mashhadani MN, Kariuki S, Msefula CL, Gordon MA, de Pinna E, Wain J, Heyderman RS, Obaro S, Alonso PL, Mandomando I, MacLennan CA, Tapia MD, Levine MM, Tennant SM, Parkhill J, Dougan G. 2012. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat. Genet. 44:1215-1221.
5. Reddy EA, Shaw AV, Crump JA. 2010. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 10:417-432.
6. Hohmann EL. 2001. Nontyphoidal salmonellosis. Clin. Infect. Dis. 32:263-269.
7. Molyneux EM, Mankhambo LA, Phiri A, Graham SM, Forsyth H, Phiri A, Walsh AL, Wilson LK, Molyneux ME. 2009. The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006. Ann. Trop. Paediatr. 29:13-22.
8. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BG, Doucka Y, Flamen A, Mordmuller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q, Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, Mtoro A, Sykes A, Ahmed S, Urassa AM, Ali AM, Mwangoka G, Tanner M, Tinto H, D'Alessandro U, Sorgho H, Valea I, Tahita MC, Kabore W, Ouedraogo S, Sandrine Y, Guiguemde RT, Ouedraogo JB, Hamel MJ, Kariuki S, Odero C, Oneko M, Otieno K, Awino N, Omoto J, Williamson J, Muturi-Kioi V, Laserson KF, Slutsker L, Otieno W, Otieno L, Nekoye O, Gondi S, Otieno A, Ogutu B, Wasuna R, Owira V, Jones D, Onyango AA, Njuguna P, Chilengi R, Akoo P, Kerubo C, Gitaka J, Maingi C, Lang T, Olotu A, Tsofa B, Bejon P, Peshu N, Marsh K, Owusu-Agyei S, Asante KP, Osei-Kwakye K, Boahen O, Ayamba S, Kayan K, Owusu-Ofori R, Dosoo D, Asante I, Adjei G, Adjei G, Chandramohan D, Greenwood B, Lusingu J, Gesase S, Malabeja A, Abdul O, Kilavo H, Mahende C, Liheluka E, Lemnge M, Theander T, Drakeley C, Ansong D, Agbenyega T, Adjei S, Boateng HO, Rettig T, Bawa J, Sylverken J, Sambian D, Agyekum A, Owusu L, Martinson F, Hoffman I, Mvalo T, Kamthunzi P, Nkomo R, Msika A, Jumbe A, Chome N, Nyakuipa D, Chintedza J, Ballou WR, Bruls M, Cohen J, Guerra Y, Jongert E, Lapierre D, Leach A, Lievens M, Ofori-Anyinam O, Vekemans J, Carter T, Leboulleux D, Loucq C, Radford A, Savarese B, Schellenberg D, Sillman M, Vansadia P. 2011. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365:1863-1875.
9. Sigauque B, Roca A, Mandomando I, Morais L, Quinto L, Sacarlal J, Macete E, Nhamposa T, Machevo S, Aide P, Bassat Q, Bardaji A, Nhalungo D, Soriano-Gabarro M, Flannery B, Menendez C, Levine MM, Alonso PL. 2009. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr. Infect. Dis. J. 28:108-113.
10. United Nations Development Programme. The millennium development goals. United Nations Development Program, New York, NY. http://www.undp.org/content/ undp/en/home/mdgoverview/.
11. Gilks CF, Brindle RJ, Otieno LS, Simani PM, Newnham RS, Bhatt SM, Lule GN, Okelo GB, Watkins WM, Waiyaki PG. 1990. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 336:545-549.
12. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL, Corkill JE, Hart CA, Gilks CF, Molyneux ME. 2002. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS (Lond.) 16:1633-1641.
13. Mabey DC, Brown A, Greenwood BM. 1987. Plasmodium falciparum malaria and Salmonella infections in Gambian children. J. Infect. Dis. 155:1319-1321.
14. Calis JC, Phiri KS, Faragher EB, Brabin BJ, Bates I, Cuevas LE, de Haan RJ, Phiri AI, Malange P, Khoka M, Hulshof PJ, van Lieshout L, Beld MG, Teo YY, Rockett KA, Richardson A, Kwiatkowski DP, Molyneux ME, van Hensbroek MB. 2008. Severe anemia in Malawian children. N. Engl. J. Med. 358:888-899.
15. Bachou H, Tylleskar T, Kaddu-Mulindwa DH, Tumwine JK. 2006. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda. BMC Infect. Dis. 6:160.
16. Kingsley RA, Msefula CL, Thomson NR, Kariuki S, Holt KE, Gordon MA, Harris D, Clarke L, Whitehead S, Sangal V, Marsh K, Achtman M, Molyneux ME, Cormican M, Parkhill J, MacLennan CA, Heyderman RS, Dougan G. 2009. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res. 19:2279-2287.
17. Kariuki S, Revathi G, Gakuya F, Yamo V, Muyodi J, Hart CA. 2002. Lack of clonal relationship between non-typhi Salmonella strain types from humans and those isolated from animals living in close contact. FEMS Immunol. Med. Microbiol. 33:165-171.
18. Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Muyodi J, Githinji JW, Kagendo D, Munyalo A, Hart CA. 2006. Invasive multidrug-resistant non-typhoidal Salmonella infections in Africa: zoonotic or anthroponotic transmission? J. Med. Microbiol. 55:585-591.
19. MacLennan CA, Gondwe EN, Msefula CL, Kingsley RA, Thomson NR, White SA, Goodall M, Pickard DJ, Graham SM, Dougan G, Hart CA, Molyneux ME, Drayson MT. 2008. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J. Clin. Invest. 118:1553-1562.
20. Gondwe EN, Molyneux ME, Goodall M, Graham SM, Mastroeni P, Drayson MT, MacLennan CA. 2010. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc. Natl. Acad. Sci. U. S. A. 107:3070-3075.
21. MacLennan CA. 2013. Antibodies and protection to Salmonella, speaker abstr, p 19. 8th Int. Conf. Typhoid Fever Other Invasive Salmonelloses, Dhaka, Bangladesh.
22. Fields PI, Swanson RV, Haidaris CG, Heffron F. 1986. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. U. S. A. 83:5189-5193.
23. MacLennan CA, Gilchrist JJ, Gordon MA, Cunningham AF, Cobbold M, Goodall M, Kingsley RA, van Oosterhout JJ, Msefula CL, Mandala WL, Leyton DL, Marshall JL, Gondwe EN, Bobat S, Lopez-Macias C, Doffinger R, Henderson IR, Zijlstra EE, Dougan G, Drayson MT, MacLennan IC, Molyneux ME. 2010. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 328:508-512.
24. Goh YS, Necchi F, Rondini S, O'Shaughnessy CM, Micoli F, Gavini M, Msefula CL, Gondwe EN, Mandala WL, Gordon MA, Saul A, MacLennan CA. 2013. Bactericidal potential of S. Typhimurium LPS-specific antibodies from HIV-infected African adults, abstr 74, p 12. 8th Int. Conf. Typhoid Fever Other Invasive Salmonelloses, Dhaka, Bangladesh.
25. Siggins MK, Cunningham AF, Silva SS, Necchi F, Coward C, Henderson IR, MacLennan CA. 2013. O-antigen of invasive African nontyphoidal Salmonella is a major target of bactericidal antibodies, abstr 84, p 21. 8th Int. Conf. Typhoid Fever Other Invasive Salmonelloses, Dhaka, Bangladesh.
26. Rondini S, Lanzilao L, Necchi F, O'Shaughnessy CM, Micoli F, Saul A, MacLennan CA. 2013. Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens. Microb. Pathog. 63C: 19-23.
27. Rondini S, Micoli F, Lanzilao L, Stefanetti G, Gavini M, Saul A, MacLennan CA. 2013. Immune response-driven design of glycoconjugate vaccines against NTS, aabstr 99, p 33. 8th Int. Conf. Typhoid Fever Other Invasive Salmonelloses, Dhaka, Bangladesh.
28. Simon R, Wang JY, Boyd MA, Tulapurkar ME, Ramachandran G, Tennant SM, Pasetti M, Galen JE, Levine MM. 2013. Sustained protection in mice immunized with fractional doses of Salmonella enteritidis core and O polysaccharide- flagellin glycoconjugates. PLoS One 8:e64680. doi:10.1371/journal.pone.0064680.
29. Boyd MA, Tennant SM, Saague V, Simon R, Muhsen K, Ramachandran G, Pasetti MF, Galen JE, Levine MM. 2013. The development of serum bactericidal assays to evaluate Salmonella vaccines, abstr P13, p 114. 16th Annu. Conf. Vaccine Res., Baltimore, MD.
30. Jertborn M, Haglind P, Iwarson S, Svennerholm AM. 1990. Estimation of symptomatic and asymptomatic Salmonella infections. Scand. J. Infect. Dis. 22:451-455.
31. Clumeck N, Mascart-Lemone F, de Maubeuge J, Brenez D, Marcelis L. 1983. Acquired immune deficiency syndrome in Black Africans. Lancet i:642.
32. Jacobs JL, Gold JW, Murray HW, Roberts RB, Armstrong D. 1985. Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 102:186-188.
33. Robbins JB, Kenny K, Suter E. 1965. The isolation and biological activities of rabbit γM- and γG-anti-Salmonella typhimurium antibodies. J. Exp. Med. 122:385-402.
34. Gil-Cruz C, Bobat S, Marshall JL, Kingsley RA, Ross EA, Henderson IR, Leyton DL, Coughlan RE, Khan M, Jensen KT, Buckley CD, Dougan G, MacLennan IC, Lopez-Macias C, Cunningham AF. 2009. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc. Natl. Acad. Sci. U. S. A. 106:9803-9808.
35. Cunningham AF, Gaspal F, Serre K, Mohr E, Henderson IR, Scott-Tucker A, Kenny SM, Khan M, Toellner KM, Lane PJ, MacLennan IC. 2007. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. 178:6200-6207.
36. Simon R, Tennant SM, Wang JY, Schmidlein PJ, Lees A, Ernst RK, Pasetti MF, Galen JE, Levine MM. 2011. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis. Infect. Immun. 79:4240-4249.